Browse by Series:

FDA Approval in CLL, Recommendation in NSCLC, Missed Endpoint in GBM Study, and More

Laura Jones
Published: Wednesday, Mar 09, 2016

Slider Left
Slider Right
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x